DPHS Stock UPDATES Dephasium Corp. (DPHS) 0.0061 09/13/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Dephasium Corp. (DPHS) 0.0061 $DPHS

OTC Daily Alert Stock Watch - Dephasium Corp (OTCBB PHS)
WorldStockWire - Thu Aug 08, 9:00PM CDT
OTC Daily Alert tracks stocks daily and is pleased to offer features on public companies. Investors can receive FREE Stock Alerts and company news and profiles by visiting OTC Daily Alert at the following: http://www.otcdailyalert.com

Dephasium Corp. Comments on Unauthorized Listing on Boerse Berlin Stock Exchange
Business Wire - Tue Jul 02, 8:36AM CDT
Dephasium Corp. (OTCBB: DPHS) would like to inform its investors and regulators that it has come to our attention that the Company's shares have been listed on the Boerse Berlin Stock Exchange ("BBSE" by an unidentified third party, without our approval, consent or knowledge. The Company did not authorize or direct any broker on the BBSE to act as a market maker for the company's common stock.

Dephasium Corp. Announces the Opening of its Online Store
Business Wire - Wed Jun 05, 7:00AM CDT
Dephasium Corp. (OTCBB: DPHS) announced today that in conjunction with Dephasium, Ltd., the opening of its online store, www.Dephasiumstore.com. The online store will enable the Company to sell the products which it is distributing in the United States and Canada in conjunction with its Distribution Agreement with Dephasium, Ltd. For all online sales sold within the United States and Canada, the Company will receive 30% of the revenues generated from those sales.

Dephasium Corp. Announces the Entry of an Exclusive Distribution Agreement with Dephasium Ltd.
Business Wire - Tue Jun 04, 7:00AM CDT
Dephasium Corp. (OTCBB: DPHS) announced today that it has entered into an exclusive distribution agreement with Dephasium Ltd to make and sell Dephasium Ltd.'s products in the United States and Canada. The agreement provides for a term of five years with successive five year renewals. Pursuant to the Agreement, the Company will receive a fee equal to 30% of all sales in the United States and Canada. Dephasium Ltd. has agreed to train the Company's staff and to help in the marketing of the products.

Dephasium Corp. Announces the Completion of Its $1.2 Million Acquisition
Business Wire - Mon Jun 03, 7:00AM CDT
Dephasium Corp. (OTCBB: DPHS) confirmed today that it has completed the acquisition of the ANCILIA patent and trademark, Registration Number 4,085,620 (the "Assets" . In return for the Assets, the Company issued to Dephasium, Ltd., a United Kingdom limited partnership, 70,000,000 shares of its restricted common stock. The negotiations leading up to the acquisition were at arms length and prior to the acquisition, the owners of the United Kingdom partnership had no relation with the Company. The Company valued the acquisition of the assets at $1.2 million. The acquisition and the closing were reported in the Company's 8-K's as filed with the SEC on March 5, 2013 and April 18, 2013.

Dephasium Corp. Announces Its Entry into an Investment Relations Consulting Agreement with www.DesignIRFirm.com
Business Wire - Fri May 31, 12:00PM CDT
Dephasium Corp. (OTCBB: DPHS) announced today that it had entered into an agreement to retain DesignIRFirm as the Company's investor relations and capital markets firm to advise and support the Company with its investor communications and marketing efforts, with a particular focus on building the Company's investor relations strategy. DesignIRFirm is a California-based investor relations firm. DesignIRFirm provides investor relations, business development and capital markets advice and support to primarily OTC-listed companies. For the services, the Company will pay $2,000 per month and no stock compensation.

Dephasium names J Francisco Terreforte as new president and director
M2 - Mon May 27, 7:28AM CDT
Dephasium Corp (OTCBB PHS), a technology company, named on Friday J Francisco Terreforte as its new president and director, replacing the resigning Irma N Colon-Alonso from her positions as president, secretary and director of the company at the close of business on 22 May 2013.




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Stephanie L. Beiermann Shines in HR Consulting Honors

Updated Category News Views 114

Celebrating a Star in Payroll Optimization Ah, the name Stephanie L. Beiermann’s been making the rounds lately, catching eyes with her lauded expertise in payroll optimization and human resources. This recognition doesn’t come out of thin air—no, it’s anchored on a solid foundation of over 25 years of cutting through the fluff to sharpen operational edges. We’re...

Continue Reading
AvidXchange Acquisition Faces Fairness Investigation

Updated Category News Views 317

Unpacking the AvidXchange Turmoil Staring at the ticker tape feels like watching a drama unfold, and today it's all about AvidXchange Holdings, Inc. (NASDAQ: AVDX). Levi & Korsinsky, LLP has launched an investigation into the fairness of its acquisition, and let me tell you, when the suits start poking around, it means someone smells a rat. The deal in question? A buyout...

Continue Reading
Snowhawk Enters Telarus as Digital Demand Gets Serious

Updated Category News Views 7

Telarus just pulled another serious capital partner into the room, and that matters more than the usual law-firm victory lap. Snowhawk Partners has invested in the technology services distributor alongside Columbia Capital, which remains a long-standing partner. Nobody disclosed a valuation, ownership percentage, financing mix, or closing date. Annoying? Sure. But the...

Continue Reading
Lecanemab Shines in 5-Year Alzheimer's Study at CTAD

Updated Category News Views 172

Latest Lecanemab Results Turn Heads at CTAD 2026 The whispers buzzing out of the CTAD 2026 conference are about something promising for those in the trenches of Alzheimer's research: lecanemab. Yep, it's a name that's been bandied about before, and this time it's the long-term data doing the talking. The five-year results from Eisai and Biogen's lecanemab study are...

Continue Reading
Giovanni Recalde Sues County After False Report

Updated Category News Views 215

Justice and Reputation: A Mix-Up Costs Big When the cops screw up, sometimes they really take the cake. That's what Giovanni Recalde learned, the hard way, when his name got tangled in a mess related to a gambling operation he wasn't even a part of. Prince William County police pasted his name into their daily incident report last year like it was no big deal. But it...

Continue Reading
Amdocs Faces a Storm: Investor Alert as Legal Probe Begins

Updated Category News Views 64

Amdocs' Recent Crisis: What Investors Need to Know Lately, it seems Amdocs Limited (NASDAQ: DOX) has found itself knee-deep in a situation that could make seasoned investors cringe. November shone some harsh light on the company's operations, a move that’s attracted attention from Schall, Brown & Schwartz LLP (“SBS”), a name not exactly foreign to shareholder...

Continue Reading
OREF Opens $185,000 Research Grant Funding Cycle Today

Updated Category News Views 66

A hundred grand aimed at better graft science is not pocket change, but it is not a finished clinical program either. That distinction matters with the Orthopaedic Research and Education Foundation's newly opened $185,000 grant cycle. This is targeted, early-to-midstream research support: the sort of money that can produce usable data, sharpen a clinical question, and...

Continue Reading
Armada Moves up as Key Player in US SI Exports

Updated Category News Views 207

Pioneering New Grounds in Intelligence Infrastructure Hell of a move by Armada, stepping into the limelight as a priority team leader in the U.S. SI Exports Program. The whole gig is under the Department of Commerce's belt, pushing the frontier of America's Super Intelligence (SI) technology to buddies across the globe. It's like watching the next big blockbuster unfold...

Continue Reading
Intel Faces Class Action Over Alleged Securities Fraud

Updated Category News Views 122

Intel's Legal Predicament: Decoding the Lawsuit Saddle up, folks, because Intel (NASDAQ: INTC) has found itself tangled in legal vines again. This ain't their first rodeo, and probably won't be their last. We're looking at a hefty class action lawsuit rallying on claims that Intel misled investors with optimistic yarns about their health. SBS Law, waving the litigation...

Continue Reading
Lake Ridge's Strong Quarter Meets a Book Value Hit

Updated Category News Views 26

An $8.25-per-share securities markdown is the splinter in an otherwise sturdy third-quarter report from Lake Ridge Bancorp. The bank earned $9.8 million, or $4.97 per common share, for the quarter ended September 30, 2026. That is up from $9.0 million, or $4.59 per share, in the prior quarter and $7.7 million, or $3.94 per share, a year earlier. Those are not flimsy...

Continue Reading

Top 5 Most Recently Viewed Articles

T-Mobile US: A Decade of Impressive Stock Growth Revealed

Updated Category News Views 142

T-Mobile US and Its Remarkable Growth Journey T-Mobile US (NASDAQ: TMUS) has shown exceptional growth over the last decade. With an annualized return rate of 20.05%, the company has outpaced the broader market by 8.22%. As of the latest information available, T-Mobile's market capitalization stands at an impressive $269.40 billion, highlighting its substantial position...

Continue Reading
Analysts Adjust TFI International's Forecasts After Q3 Report

Updated Category News Views 67

TFI International Reports Weaker-Than-Expected Q3 Earnings After the market closed on a recent Monday, TFI International (NYSE: TFII) announced its quarterly earnings figures, which unfortunately fell below expectations. The company reported earnings of $1.60 per share, compared to analyst predictions of $1.78 per share. In addition, TFI International's quarterly revenue...

Continue Reading
C3.ai Investors Face Class Action Amidst Poor Financial Results

Updated Category News Views 179

C3.ai Class Action Overview The Portnoy Law Firm is stepping forward to represent investors of C3.ai, Inc. as a class action develops. This legal move comes after concerning preliminary financial results announced by the company. Investors who purchased securities of C3 during the specified class period are encouraged to engage with the firm. Details of the Legal Class...

Continue Reading
21st.BIO Seeks EU Nod for Precision Fermentation Tech

Updated Category News Views 172

Is Precision Fermentation Europe's Next Big Bet? Here we go again with another tech trying to revolutionize the food industry, and this time it's the Danish company 21st.BIO making strides in Europe. They've tossed their hat in the ring with an EU Novel Food application for BLG Essential+™, hoping to weave precision fermentation into the fabric of European food...

Continue Reading
Key Pfizer Executives Support Current Leadership Amid Challenges

Updated Category News Views 105

Support for Pfizer's Leadership from Former Executives In a recent statement, former Pfizer executives, Ian Read and Frank D'Amelio, clarified their stance regarding the ongoing campaign by activist investor Starboard Value. They emphasized that they will not be engaging with Starboard, which has been advocating for changes within the pharmaceutical giant to enhance its...

Continue Reading